Jill Storry/LinkedIn
Jan 26, 2026, 05:27
Jill Storry on Alloimmune Hemolytic Disease of the Fetus And Newborn
Jill Storry, Adjunct Professor at Department of Laboratory Medicine, Divisions of Hematology and Transfusion Medicine, Lund University, shared on LinkedIn:
”Pleased to share this review – a very nice collaboration with my colleagues in Japan, Professor Ohto and Professor Nollet!”
Read the full article here.
Article: Five Pathogenetic Classifications for Alloimmune Hemolytic Disease of the Fetus And Newborn
Authors: Hitoshi Ohto, Kenneth E. Nollet, Jill R. Storry
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy
-
Sep 23, 2026, 00:07Arun V J: How Does a Good Conference Destroy My Ego?
-
Sep 23, 2026, 00:06Akshat Jain: Sickle Cell Disease Is Not One Size Fits All
-
Sep 23, 2026, 00:05Sherri Ozawa: Nicole De Vita’s Iron Deficiency Infographic Recognized at SABM
-
Sep 23, 2026, 00:04Zafar Ali: How Does Hemoglobin Know When to Hold Oxygen and When to Let It Go?
-
Sep 23, 2026, 00:02Ahmed Elsharkawy: Drug-Drug and Drug-Diluent Incompatibilities in ICUs and Hematology Units
-
Sep 22, 2026, 23:58Nishant Rajendra Tiwari: Hereditary TTP With the Same ADAMTS13 Variants but Strikingly Different Disease Courses
-
Sep 22, 2026, 23:57Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia
-
Sep 22, 2026, 23:56Nathan Punwani: EASIX and sC5b-9 Predict TMA After Allogeneic Stem Cell Transplantation